ConductScience.org, home

Paper3947503

Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative.

Vital Durand D and 4 others. Br J Clin Pharmacol, 1986. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative. Papers, record 3947503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3947503

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Induction of mixed function oxidase activity in man by rifapentine (MDL 473), a long-acting rifamycin derivative.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1986
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
1.06
iCite
Revised in PubMed
2019-05-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vital Durand DD
2Hampden CC
3Boobis ARA R
4Park BKB K
5Davies DSD S

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mixed Function OxygenasesMajor topic
RifampinMajor topic
Adult
Antipyrine
Biotransformation
Enzyme Induction
Half-Life
Humans
Hydrocortisone
Male
Saliva
Time Factors

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14723259Dose-dependent enzyme induction.Clin Pharmacol Ther1973https://conductscience.org/library/papers/4723259PubMed
26508979Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6508979PubMed
34593769The effect of spironolactone on antipyrine metabolism in man.Pharmacology1973https://conductscience.org/library/papers/4593769PubMed
4973966Assessment of antipyrine kinetics by measurement in saliva.Br J Clin Pharmacol1976https://conductscience.org/library/papers/973966PubMed
5849823Induction of hepatic microsomal enzymes after brief administration of rifampicin in man.Gastroenterology1977https://conductscience.org/library/papers/849823PubMed
6140033Pharmacokinetic interactions with rifampicin.Clin Pharmacokinet1977https://conductscience.org/library/papers/140033PubMed
7728306Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings].Br J Clin Pharmacol1978https://conductscience.org/library/papers/728306PubMed
8745397A direct radioimmunoassay for 6 beta-hydroxycortisol in human urine.J Steroid Biochem1978https://conductscience.org/library/papers/745397PubMed
9111889The antipyrine test in clinical pharmacology: conceptions and misconceptions.Clin Pharmacol Ther1979https://conductscience.org/library/papers/111889PubMed
10480161High-pressure liquid chromatographic analysis of antipyrine in small plasma samples.J Pharm Sci1979https://conductscience.org/library/papers/480161PubMed
11533575Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.Br J Clin Pharmacol1979https://conductscience.org/library/papers/533575PubMed
125229064,4'-Dihydroxyphenazone as an urinary metabolite of phenazone in different species including man.Naunyn Schmiedebergs Arch Pharmacol1979https://conductscience.org/library/papers/522906PubMed
136113907Clinical implications of enzyme induction and enzyme inhibition.Clin Pharmacokinet1981https://conductscience.org/library/papers/6113907PubMed
146791958Method for determination of DL 473-IT and its metabolite L 14583 in plasma of humans, monkeys and rats.Farmaco Prat1981https://conductscience.org/library/papers/6791958PubMed
157028436Metabolism and pharmacokinetics of the antibiotic rifampin.Drug Metab Rev1981https://conductscience.org/library/papers/7028436PubMed
167059439Effect of rifampicin on metoprolol and antipyrine kinetics.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7059439PubMed
177341283Differential induction of antipyrine metabolism by rifampicin.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7341283PubMed
187075648Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7075648PubMed
196627809Interindividual variations in drug disposition. Clinical implications and methods of investigation.Clin Pharmacokinet1983https://conductscience.org/library/papers/6627809PubMed
206668316Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine.J Chromatogr1983https://conductscience.org/library/papers/6668316PubMed

See all 21 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
25512422Evaluation of the pharmacokinetic interaction between repeated doses of rifapentine or rifampin and a single dose of bedaquiline in healthy adult subjects.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25512422PubMed
22472995Safety and pharmacokinetics of escalating daily doses of the antituberculosis drug rifapentine in healthy volunteers.Clin Pharmacol Ther2012https://conductscience.org/library/papers/22472995PubMed
15762766Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure.Clin Pharmacokinet2005https://conductscience.org/library/papers/15762766PubMed
14605790Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.Eur J Clin Pharmacol2003https://conductscience.org/library/papers/14605790PubMed
10628899Cytochrome P450 3A: ontogeny and drug disposition.Clin Pharmacokinet1999https://conductscience.org/library/papers/10628899PubMed
9806107Rifapentine.Drugs1998https://conductscience.org/library/papers/9806107PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3947503

GET https://conductscience.org/api/papers/v1/3947503/references?page=2